These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 10462305)
1. Another case of focal segmental glomerulosclerosis in an acutely uraemic patient following interferon therapy. Dressler D; Wright JR; Houghton JB; Kalra PA Nephrol Dial Transplant; 1999 Aug; 14(8):2049-50. PubMed ID: 10462305 [No Abstract] [Full Text] [Related]
2. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature. Bremer CT; Lastrapes A; Alper AB; Mudad R Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597 [TBL] [Abstract][Full Text] [Related]
3. [Nephrotic syndrome with acute renal failure due to focal segmental glomerulosclerosis in a patient treated with alpha-interferon for chronic hepatitis C]. Bellaïche G; Guettier C; Duboust A; Ley G; Slama JL Gastroenterol Clin Biol; 2000 Apr; 24(4):465. PubMed ID: 10844293 [No Abstract] [Full Text] [Related]
4. Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy. Shah M; Jenis EH; Mookerjee BK; Schriber JR; Baer MR; Herzig GP; Wetzler M Cancer; 1998 Nov; 83(9):1938-46. PubMed ID: 9806652 [TBL] [Abstract][Full Text] [Related]
5. Life-threatening thrombocytopenia and nephrotic syndrome due to focal segmental glomerulosclerosis associated with pegylated interferon alpha-2b and ribavirin treatment for hepatitis C. Alves Couto C; Costa Faria L; Dias Ribeiro D; de Paula Farah K; de Melo Couto OF; de Abreu Ferrari TC Liver Int; 2006 Dec; 26(10):1294-7. PubMed ID: 17105597 [TBL] [Abstract][Full Text] [Related]
7. Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient. Kunin M; Kopolovic J; Avigdor A; Holtzman EJ Nephrol Dial Transplant; 2004 Mar; 19(3):723-6. PubMed ID: 14767032 [No Abstract] [Full Text] [Related]
8. Stabilization of hepatitis C associated collapsing focal segmental glomerulosclerosis with interferon alpha-2a and ribavirin. Sperati CJ Clin Nephrol; 2013 Sep; 80(3):231-4. PubMed ID: 22541681 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy. Costero O; Picazo ML; Zamora P; Romero S; Martinez-Ara J; Selgas R Nephrol Dial Transplant; 2010 Mar; 25(3):1001-3. PubMed ID: 20019017 [TBL] [Abstract][Full Text] [Related]
10. A woman with chronic hepatitis C infection and nephrotic syndrome who developed multiple renal lesions after interferon alfa therapy. Fisher ME; Rossini M; Simmons E; Harris RC; Moeckel G; Zent R Am J Kidney Dis; 2004 Sep; 44(3):567-73. PubMed ID: 15332232 [No Abstract] [Full Text] [Related]
11. Development of proteinuria and focal segmental glomerulosclerosis during direct-acting antiviral therapy for hepatitis C virus infection. Hogan JJ; Lim MA; Palmer MB; Bloom RD; Chung RT; Sise ME Hepatology; 2017 Aug; 66(2):658-660. PubMed ID: 28211090 [No Abstract] [Full Text] [Related]
12. Nephrotic-range proteinuria following pamidronate therapy in a patient with metastatic breast cancer: mitochondrial toxicity as a pathogenetic concept? Sauter M; Jülg B; Porubsky S; Cohen C; Fischereder M; Sitter T; Schlondorff D; Gröne HJ Am J Kidney Dis; 2006 Jun; 47(6):1075-80. PubMed ID: 16731304 [No Abstract] [Full Text] [Related]
13. Pamidronate-induced kidney injury in a patient with metastatic breast cancer. Nagahama M; Sica DA Am J Med Sci; 2009 Sep; 338(3):225-8. PubMed ID: 19581797 [TBL] [Abstract][Full Text] [Related]
14. Focal segmental glomerulosclerosis and lithium treatment. Schreiner A; Waldherr R; Rohmeiss P; Hewer W Am J Psychiatry; 2000 May; 157(5):834. PubMed ID: 10784485 [No Abstract] [Full Text] [Related]